22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      On Goldilocks, care coordination, and palliative care: making it ‘just right’

      editorial

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hospice/palliative care is not just end-of-life care, it is specialised medical care for patients with serious illness. 1 Although definitions of “serious illness” may vary, it is clear that far more patients could benefit from hospice/palliative care than we can actually serve, given the existing workforce challenges and the lack of clarity in how to pay for specialist palliative care throughout the world. The needs of patients and caregivers are similar regardless of the underlying life limiting illness. 2–4 Appropriate timing of referrals is key, but this timing must be clearly defined for each disease group, with differences to be expected between cancer and COPD. 5 Not every patient needs to see a palliative care specialist, and the timing matters greatly when resources are limited. 6 Thus, as palliative care continues to move further upstream in a patient's journey, these limitations necessitate that we be better able to match the right type of care with the right patient at the right time. Models of “care coordination” offer one potentially promising strategy for addressing this problem. In this issue of the PCRJ, Epiphaniou and colleagues 7 report the results of a longitudinal qualitative study of patients' experiences with end-of-life care coordination in the UK. These results highlight several important truths about the current state of care coordination. First, patients with COPD had little access to care coordinators (or “keyworkers” as they are called here). These patients are at risk for increasingly frequent re-hospitalisations as the disease progresses, and avoiding hospital is a crucial way of improving care and decreasing healthcare costs. Given the very long illness trajectory for people with COPD, 8 they may seem less in need of care coordination, and are often left without easy access to close follow-up care after hospital discharge. Patients with COPD in this study expressed a sense of feeling left out on their own without much support. Patients with lung cancer, on the other hand, routinely had access to a care coordinator. 7 Among those who did, nearly all felt it was valuable. These findings highlight the remarkably positive role care coordinators can play in the life of a patient with serious illness. Patients frequently described how useful the coordinator was in responding to their needs by matching them with various services, and helping them contact their physicians. The complex care needed for those with advanced illness can be very overwhelming and patients may need a “disease shepherd” to help show them the way. These key concepts of care coordination are central to the care that is provided by hospice/palliative care services around the world. Such care might be expected to result in fewer emergency department visits or hospital stays for patients with serious, progressive illnesses. Interestingly, despite its intuitive appeal, care coordination actually does not always result in improved outcomes. In fact, published studies have been somewhat mixed. For example, a similar concept was tested in the US cancer setting, using “nurse navigators.” 9 In a randomised controlled trial, this intervention yielded improvements in psychosocial care, care coordination, and patient information, but actually did not improve quality of life. It also did not reduce costs, except in a subset with lung cancer. Similarly, in a large randomised trial of a tele-health intervention for patients with COPD, 10 a daily symptom and medication monitoring approach was not effective in reducing re-hospitalisations or improving quality of life. Though slightly different from care coordinators, this finding puts forward the challenge of how best to apply findings from the study by Epiphaniou et al. 7 to populations of people with COPD. Another noteworthy study of care coordination is the “Palliative Care Trial.” 11,12 Here, the implementation of a single patient-focused case conference, coordinated by a palliative care nurse in concert with the general practitioner (GP), was shown to reduce hospitalisations by 26% and to provide better maintenance of performance status. The nurse and GP assessed the patient's needs and translated these to the multidisciplinary case conference, bringing the patient's voice to the plan of care. This approach embodies the “disease shepherd” model by helping match the right support services to the right patient in a timely way. Referrals and use of scarce resources are thus based on need, rather than diagnosis or prognosis. As so conceived, a care coordinator may be the very steward that we need to judiciously expand palliative care services to those patients who are particularly likely to need and/or benefit from accessing them. In heart failure, a nurse-led intervention comprising comprehensive education, social-service consultation, and intensive follow-up reduced 90-day heart failure readmission by 56.2%, improved quality of life, and reduced the cost of care. 13 A meta-analysis of published trials of post-discharge support strategies further supports these findings. 14 In contrast, enhanced access to primary care for heart failure patients did not improve their self-reported health status and was actually associated with more frequent hospitalisation. 15 Reconciling these findings will be important in moving science forward in this area. In the end, what do these somewhat contradictory results mean for hospice/palliative care, and for clinicians who face the difficult decision about timing a referral or who are trying to adopt a model of care coordination? Wherein lies the “transition point” — the “Goldilocks point” — where it is exactly the right time to mobilise specialist hospice/palliative care services for the patient sub-group who will derive the most benefit? Whilst we do not pretend to have all the answers, we do propose a path forward in terms of further research. More work is needed to explore the role of functional limitations, the onset of troublesome symptoms, or both, as a potentially useful threshold to trigger further care coordination. The onset of functional decline often portends a poor prognosis, especially in cancer settings, 16 and symptoms often signal an impending need for emergency or inpatient services. Symptoms can now be monitored in the home using emerging technological applications, 17 and once decline is noted, care coordination could be mobilised to assess the potential need for additional services. More active use of mobile health technology solutions is likely to play an important role in solving this puzzle, helping us match the right care to the right patient at the right time. Care coordinators will not fix all of palliative care's service planning problems, but are a key part of the solution if appropriately applied. Regardless, further study is needed not only on their impact on patients, but also on patients' caregivers.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          A community population survey of prevalence and severity of dyspnea in adults.

          Given the progress in the symptomatic treatment of breathlessness, and the physical and psychological morbidity associated with chronic breathlessness, estimates of the size of the population that may benefit from better support become imperative. Prevalence estimates have varied widely (0.9% of clinical encounters to 32%) and have largely relied only on respondents who used clinical services. Whole-of-population approaches may be able to define better the "true" prevalence of chronic breathlessness and quantify exertion limited by breathlessness. The aim of this study was to estimate population levels of chronic breathlessness, severity of limits to exercise, and demographic predictors of the presence of breathlessness. A whole-of-population face-to-face survey method (n=8,396) in South Australia was used, directly standardized for age, gender, country of birth, and rurality. Respondents were asked about breathlessness and levels of exertion causing breathlessness for at least three of the last six months using a modified Medical Research Council dyspnea scale. Univariate and multivariate analyses identify the demographic characteristics of people more likely to experience chronic breathlessness. With a participation rate of 65.3%, 8.9% of respondents had breathlessness that chronically limited exertion. Significant associations with chronic breathlessness in multivariate analysis included female sex (P<0.001), not working full time (P<0.001), low income (P=0.007), and older age (P=0.031). There are significant levels of chronic breathlessness in the community. Given the prevalence, it is feasible to explore the onset of breathlessness, the underlying etiologies and subsequent health service utilization, and health consequences.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Delivery strategies to optimize resource utilization and performance status for patients with advanced life-limiting illness: results from the "palliative care trial" [ISRCTN 81117481].

            Evidence-based approaches are needed to improve the delivery of specialized palliative care. The aim of this trial was to improve on current models of service provision. This 2×2×2 factorial cluster randomized controlled trial was conducted at an Australian community-based palliative care service, allowing three simultaneous comparative effectiveness studies. Participating patients were newly referred adults, experiencing pain, and who were expected to live >48 hours. Patients enrolled with their general practitioners (GPs) and were randomized three times: 1) individualized interdisciplinary case conference including their GP vs. control, 2) educational outreach visiting for GPs about pain management vs. control, and 3) structured educational visiting for patients/caregivers about pain management vs. control. The control condition was current palliative care. Outcomes included Australia-modified Karnofsky Performance Status (AKPS) and pain from 60 days after randomization and hospitalizations. There were 461 participants: mean age 71 years, 50% male, 91% with cancer, median survival 179 days, and median baseline AKPS 60. Only 47% of individuals randomized to the case conferencing intervention received it; based on a priori-defined analyses, 32% of participants were included in final analyses. Case conferencing reduced hospitalizations by 26% (least squares means hospitalizations per patient: case conference 1.26 [SE 0.10] vs. control 1.70 [SE 0.13], P=0.0069) and better maintained performance status (AKPS case conferences 57.3 [SE 1.5] vs. control 51.7 [SE 2.3], P=0.0368). Among patients with declining function (AKPS <70), case conferencing and patient/caregiver education better maintained performance status (AKPS case conferences 55.0 [SE 2.1] vs. control 46.5 [SE 2.9], P=0.0143; patient/caregiver education 54.7 [SE 2.8] vs. control 46.8 [SE 2.1], P=0.0206). Pain was unchanged. GP education did not change outcomes. A single case conference added to current specialized community-based palliative care reduced hospitalizations and better maintained performance status. Comparatively, patient/caregiver education was less effective; GP education was not effective. Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Specialist palliative care needs of whole populations: a feasibility study using a novel approach.

              Defining whether people with life-limiting illnesses (PLLI) who do not access specialized palliative care services (SPCS) have unmet needs is crucial in planning and evaluating palliative care. This study seeks to establish the viability of a whole-of-population method to help characterize SPCS access through proxy report. Questions were included in a piloted annual face-to-face health survey of 3027 randomly selected South Australians on the need for, uptake rate of, and satisfaction with SPCS in 2000. The survey was representative of the cross-section of South Australians by age, gender, socioeconomic status and region. One in three people surveyed (1069) indicated that someone 'close to them' had died of a terminal illness in the preceding five years. Of those who identified that a palliative service had not been used (38%, 403), reasons cited included family/friends provided the care (34%, 136) and the service was not wanted (21%, 86). Respondents with income > AU dollars 60000 per year were more likely to report that a SPCS had been used (P = 0.01). People who had cancer as their life-limiting illness were more likely to access SPCS (P < 0.001). The results generate a model comparing SPCS utilization with client benefit. The survey was acceptable to interviewees. Uptake rates of SPCS in this survey are consistent with other South Australian whole population estimates of SPCS utilization. Although there are limitations in this survey approach and the questions asked, this method can be developed to improve our understanding of the characteristics and needs of PLLI and their carers.
                Bookmark

                Author and article information

                Journal
                Prim Care Respir J
                Prim Care Respir J
                Primary Care Respiratory Journal: Journal of the General Practice Airways Group
                Nature Publishing Group
                1471-4418
                1475-1534
                March 2014
                19 February 2014
                : 23
                : 1
                : 8-10
                Affiliations
                [1 ]Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine , Durham, NC USA
                [2 ]Center for Learning Health Care, Duke Clinical Research Institute , Durham, NC USA
                [3 ]Discipline, Palliative and Supportive Services, Flinders University , Adelaide, Australia
                [4 ]Division of Medical Oncology, Department of Medicine, Duke University School of Medicine , Durham, NC USA
                Author notes
                [* ]Box 3436, Duke University Medical Center , Durham, NC 27710 Tel: 919 668 0647 Fax: 919-681-7985 E-mail: amy.abernethy@ 123456duke.edu
                Article
                pcrj201417
                10.4104/pcrj.2014.00017
                6442284
                24553823
                fce9d056-e263-4c1d-86e6-c48241900b03
                Copyright © 2014 Primary Care Respiratory Society UK
                History
                : 11 February 2014
                Categories
                Editorial

                Comments

                Comment on this article